✦ LIBER ✦

Association of sleep duration and breast cancer OncotypeDX recurrence score

✍ Scribed by Cheryl L. Thompson, Li Li

Book ID: 118144489
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 269 KB
Volume: 134
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-012-2144-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5165 POSTER Clinical Use of OncotypeDX R

5165 POSTER Clinical Use of OncotypeDX Recurrence Score as an Adjuvant-Treatment Decision Tool in Early Breast Cancer Patients

✍ Markopoulos, C.; Xepapadakis, G.; Venizelos, V.; Tsiftsoglou, A.; Misitzis, J.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Evaluation of OncotypeDX Recurrence Scor

Evaluation of OncotypeDX Recurrence Score as a prognostic factor in Japanese women with estrogen receptor-positive, node-negative primary Stage I or IIA breast cancer

✍ Kyoko Yorozuya; Toru Takeuchi; Miwa Yoshida; Yukako Mouri; Junko Kousaka; Kimihi 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 288 KB

HER2 assessment using fluorescencein sit

HER2 assessment using fluorescencein situhybridization compared with OncotypeDX and association with risk of breast cancer death

✍ FL Baehner, NS Achacoso, T Maddala, C Alexander, S Shak… 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 461 KB

Sleep duration and the risk of breast ca

Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study

✍ Kakizaki, M; Kuriyama, S; Sone, T; Ohmori-Matsuda, K; Hozawa, A; Nakaya, N; Fuku 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 84 KB

Association between standard clinical an

Association between standard clinical and pathologic characteristics and the 21-gene recurrence score in breast cancer patients : A population-based study

✍ Ido Wolf; Noa Ben-Baruch; Ronnie Shapira-Frommer; Shulamit Rizel; Hadassa Goldbe 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 1 views

## Abstract ## BACKGROUND. The 21‐gene recurrence score (RS) assay has been reported to accurately predict the risk of disease recurrence and chemotherapy benefit in women with estrogen receptor (ER)‐positive, lymph node (LN)‐negative breast cancer who are treated with tamoxifen. To the authors' k

Duration of sleep and breast cancer risk

Duration of sleep and breast cancer risk in a large population-based case–control study

✍ JANE A. McELROY; POLLY A. NEWCOMB; LINDA TITUS-ERNSTOFF; AMY TRENTHAM-DIETZ; JOH 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 541 KB